
All Products are stable to be shipped at room temperature, unless otherwise specified.
Pack Size | Quantity | Price (USD) | Sub Total |
---|---|---|---|
.5mg | $ 380.00 | 0.0 | |
5mg | $ 3318.00 | 0.0 | |
25mg | $ 12893.00 | 0.0 | |
Exact Weight Packaging | $ 145.00 | 0.0 | |
Total | $ 0.0 |
Product successfully added to cart.
- Request another packsize ? Click here.
- Inventory Status : Currently Back Ordered - Please Request Lead Time
- Ships On : 10/13/2023
F335402
Bulk Order Request for F335402
Product Description
Catalogue Number | F335402 |
Chemical Name | Fidaxomicin-D7 |
Synonyms | (3E,5E,8S,9E,11S,12R,13E,15E,18S)-3-[[[6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-β-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-β-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-oxacyclooctadeca-3,5,9,13,15-pentaen-2-one-D7; |
CAS Number | 2143934-06-7 |
Alternate CAS # | Unlabelled: 873857-62-6 |
Molecular Formula | C₅₂H₆₇D₇Cl₂O₁₈ |
Appearance | Off-White Solid |
Melting Point | >123°C (dec.) |
Molecular Weight | 1065.08 |
Storage | 4°C |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Category | Standards; Chiral Molecules; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Others; Pharmaceutical/API Drug Impurities/Metabolites; Antibotics; |
Applications | Fidaxomicin-D7 is a labelled analogue of Fidaxomicin (F335400). Fidaxomicin is a nonabsorbed macrocyclic antibiotic, and is the first antimicrobial to be approved by the FDA for the treatment of Clostridium difficile infection (CDI) in 20 years. Fidaxomicin works by inhibiting sporulation by CDI, sustaining clinical response and reducing recurrences of this pathogen. |
References | Babakhani, F., et al.: Clin. Infect. Dis., 55, S162 (2012); Venugopal, A., et al.: Clin. Infect. Dis., 54, 568 (2012) |